Key Highlights

  • SkinKandy listed on the ASX on 21 May 2026 at an offer price of AUD 2.20 and closed its first session at AUD 2.33, so an unverified screener quote near AUD 2.49 would still sit above the float price.
  • The company's ASX announcement record since listing contains no price-sensitive releases at all, only substantial holder notices, director interest notices and administrative changes.
  • Prospectus figures reported by trade press put FY25 revenue at AUD 70.1 million and net profit at AUD 6.4 million, with an FY26 forecast of AUD 88.7 million and AUD 8.6 million that has not yet been tested by a lodged full-year result.
  • The first reported result after listing will provide an important test of the prospectus forecasts and store-growth strategy.

SkinKandy joined the ASX in May at AUD 2.20 a share and has traded above its offer price ever since. A softer session has put the piercing and jewellery retailer back in view, with no company announcement to explain the move and a maiden full-year result still ahead.

Why the stock is in focus

SkinKandy Limited is one of the freshest names on the ASX boards. The Maroochydore-based operator of specialist body-piercing studios was admitted on 21 May 2026 and has barely two months of quoted history, so every session carries more weight than it would for a seasoned mid-cap.

It is also an unusual float: a single-format, service-led retailer in a market that has seen few consumer listings. That draws investors hunting growth outside resources, and sceptics wondering whether piercing services and the jewellery sold alongside them can hold their economics as the store count climbs.

The share-price movement

A TradingView screener of Australian decliners recorded ASX:SK1 at around AUD 2.49, down roughly 3.9 per cent in a single session. That figure is a point-in-time screener reading rather than a verified closing price, and Kalkine has not been able to independently confirm it against official ASX market data.

Context matters more than the day's number. SkinKandy priced its offer at AUD 2.20 a share and finished its first day at AUD 2.33, up 5.9 per cent, according to Inside Retail. If the screener quote is accurate, the stock still sits above the price new holders paid in May.

Latest announcement or development

The disclosure record is thin. Since quotation, SkinKandy has lodged substantial holder notices, initial director's interest notices, a company secretary change on 3 June 2026 and a director appointment on 16 June 2026. None carries a price-sensitive flag on the ASX platform, and no trading update or guidance has been issued.

The most recent filing of interest is a substantial holder notice lodged on 13 July 2026 covering the WMI, WAA, WAM and WAX vehicles managed by Wilson Asset Management. That says something about who is buying, not about trading conditions.

No single confirmed company-specific catalyst was identified for the share-price movement.

Recent financial and operational performance

SkinKandy lodged a 234-page prospectus, its constitution and audited accounts for FY23, FY24 and FY25 with the ASX on 20 May 2026, plus interim statements made up to 3 January 2026. Those documents sit behind the exchange's terms-of-access interstitial and could not be read for this article.

The figures Inside Retail reported from the offer documents are FY25 revenue of AUD 70.1 million and net profit of AUD 6.4 million, against an FY26 forecast of AUD 88.7 million and AUD 8.6 million. The measures that decide whether the forecast lands are not visible to us: comparable store sales, average transaction value, the service-versus-jewellery split, and gross margin.

Business model and principal assets

SkinKandy runs piercing studios inside shopping centres, mostly in Queensland, New South Wales and Victoria, and entered New Zealand in June 2024. The network stood at about 100 stores at listing, employing roughly 800 people including some 750 trained piercers.

The model pairs a service with a product: a customer books a piercing, and the jewellery inserted at the time, plus later changes and upgrades, forms the merchandise leg. Chief executive Dain Friis said in 2024 the business offered more than 60 piercing types, an unaudited company claim.

Business register records show separate state operating entities alongside operations, trading and intellectual property companies, consistent with a company-operated fleet rather than a franchise system, though filings did not let us confirm this.

Growth opportunities

The stated plan is a rollout. Inside Retail reported an ambition to grow from roughly 100 stores to between 180 and 210 sites, adding 15 to 20 a year. Richard Whiteoak, whose private equity firm was the pre-IPO controlling shareholder, described the intention as roughly doubling the network and pointed to what he called distinctive economics, arguing low fit-out costs support quick payback.

Offshore expansion is flagged rather than committed. The United Kingdom and United States have been identified as priority markets, subject to board approval. New Zealand remains the only market outside Australia where SkinKandy trades today.

Balance sheet, funding and cash flow

The float raised AUD 160 million. A SaleCo entity in the corporate register indicates the offer included a sell-down, and Whiteoak's private equity vehicle cut a pre-IPO stake reported at around 80 per cent to about 14 per cent. The split between new money for the company and proceeds paid to vendors sits in the prospectus we could not access.

Because the audited accounts were unreadable, we cannot state cash, debt, lease liabilities or operating cash flow, and no dividend has been declared. A rollout of 15 to 20 sites a year carries a continuing fit-out capital requirement to be met from operating cash flow, IPO proceeds or debt.

Principal risks

Execution risk sits at the top. Doubling a network means finding sites that trade like the existing fleet, and the marginal store in a rollout is usually weaker than the average. Labour is the binding constraint: piercing is a skilled trade, and training must scale ahead of the property pipeline.

Cost pressures cut both ways. Occupancy costs and award wage rises press on store margins, while gold and silver input costs feed straight into jewellery cost of goods. We could not verify the metal mix, sourcing or any hedging, so margin sensitivity to precious metal prices is an open question.

Other risks include discretionary spending, single-format concentration, safety compliance, and the eventual expiry of escrow on pre-IPO holdings. There is also no published broker coverage.

Valuation and investor expectations

The same unverified screener snapshot puts market capitalisation near AUD 295.92 million, a trailing price-to-earnings ratio of about 34.25 and earnings per share of roughly AUD 0.07. Those inputs are not confirmed against official market data.

Taking that capitalisation at face value purely as arithmetic, FY25 net profit of AUD 6.4 million implies a historic multiple in the mid-forties, while the FY26 forecast of AUD 8.6 million implies something closer to the mid-thirties. That is our own calculation, not a company or broker statement.

We are not quoting EV/EBITDA, price-to-book or free cash flow yield because net debt, equity and cash flow could not be verified, and no dividend means no yield. SkinKandy is profitable, so a P/E is a meaningful lens, but multiples change continuously.

Outlook

The near-term test is straightforward. SkinKandy's first full-year result as a listed company is when the prospectus forecast of AUD 88.7 million in revenue and AUD 8.6 million in profit is met or missed, and the first disclosure letting outsiders see comparable sales, average transaction value and gross margin rather than infer them.

Beyond that, watch store openings against the 15 to 20 a year target, sales density rather than raw store count, wage and occupancy growth, and jewellery margin under metal costs. For now, one softer session in a stock with two months of history tells investors very little.